Pushing fluid myth debunked - 6minutes

Pushing fluid myth debunked 6minutes, Australia - 4 hours ago The authors refer to a recent literature review published in the nephrology press [ Journal of the American Society of Nephrology 2008; 19 1-3. ...

The ISN Clinical Practice Guidelines Committee

The ISN Clinical Practice Guidelines Committee

Nature Clinical Practice Nephrology 4, 463 (2008). doi:10.1038/ncpneph0905

Authors: Gavin J Becker, Omar Abboud, Ezequiel Bellorin-Font, Michael Field, Philip KT Li, Richard J Johnson & Christoph Wanner

In vitro studies suggest role for antihistamine clemizole in treating hepatitis C

EurekAlert: In all, the team found 18 drugs that substantially reduced NS4B binding to its target RNA, but they focused on clemizole because it is already known to be safe in humans. Quake said several of the other compounds were also interesting starting points for developing useful medicines. Should clemizole prove effective in human trials, Glenn said, it could become an essential component in a new class of multidrug treatments for hepatitis C. Other components could be drugs under development elsewhere that target specific enzymes in the virus. The goal is to improve on the current treatment, a combination of the general antiviral drugs interferon and ribavirin. Those only work about half the time, but have uncomfortable, flulike side effects.

HDCN: Relapsing MCD and FSGS; 30 new audiofiles from 8 sessions of RW07; AKI after oral phosphate

HDCN: We continue to post CNCs from RW07. This update, Alain Meyrier and Ron Hogg discuss relapse in MCD and FSGS in adults when treated with steroids and what can be done to improve remission rate. Eight new audiofile sessions from RW07 focus on AKI, RAS, Sorbents, Diabetic complications, New measures of GFR, and more. Featured review article from CJASN focuses on AKI after oral phosphate bowel preps.

How Tulane University hospital coped with Gustav evacuation

CNN: "The lesson learned last time is, don't have lot of patients in your hospital unless it is absolutely necessary, and don't have too many staff," said Bob Lynch, the hospital's CEO.